Suppr超能文献

血管健康-内皮功能及心血管疾病管理临床评估工具。

Clinical Evaluation Tool for Vascular Health-Endothelial Function and Cardiovascular Disease Management.

机构信息

Department of Vascular Medicine, Peking University Shougang Hospital, Beijing 100144, China.

Vascular Health Research Center of Peking University Health Science Center (VHRC-PKUHSC), Beijing 100191, China.

出版信息

Cells. 2022 Oct 25;11(21):3363. doi: 10.3390/cells11213363.

Abstract

There are 330 million people suffering from cardiovascular diseases (CVD) in China, and two out of every five deaths were due to CVD. CVD has become the main disease burden in China. Vascular health management can detect subclinical vascular diseases such as endothelial dysfunction. Through controlling risk factors, vascular function, such as endothelial function, can be improved and cardiovascular events can be prevented from the upstream. Peking University Shougang hospital is the first practitioner of life-long vascular health management since 2010 in China. The established Beijing Vascular Health Stratification (BVHS) focuses on the comprehensive evaluation of vascular health function and structure and explores the application of information technology and artificial intelligence in vascular health management. The life-long vascular health management and tertiary hospital-primary hospital-family service model guided by BVHS can better realize the prophylaxis of CVD. The prevention and control strategy of CVD based on information technology and vascular health, especially endothelial function management, can help to implement the "healthy China 2030" plan. In this review, we focus on advances in the clinical assessment of vascular endothelial function, including the evaluation of endothelial function, the evaluation of arteriosclerosis, new potential biological markers to provide new possible therapeutic targets, and BVHS, a comprehensive vascular aging assessment system. Strengthening the assessment of cardiovascular health and endothelial function is of great significance for the occurrence of cardiovascular diseases in risk groups and the occurrence of adverse events in patients with cardiovascular diseases.

摘要

中国有 3.3 亿心血管疾病患者,每 5 例死亡中就有 2 例死于心血管疾病。心血管疾病已成为中国主要的疾病负担。血管健康管理可以检测内皮功能障碍等亚临床血管疾病。通过控制危险因素,可以改善血管功能,如内皮功能,从而预防心血管事件的发生。北京大学首钢医院自 2010 年以来,是中国首家践行终身血管健康管理的医院。建立的北京血管健康分层(BVHS)专注于血管健康功能和结构的综合评估,并探索信息技术和人工智能在血管健康管理中的应用。由 BVHS 指导的终身血管健康管理和三级医院-一级医院-家庭服务模式,可以更好地实现 CVD 的预防。基于信息技术和血管健康的 CVD 防控策略,特别是内皮功能管理,可以帮助实施“健康中国 2030”计划。在这篇综述中,我们重点介绍了血管内皮功能的临床评估进展,包括内皮功能评估、动脉硬化评估、新的潜在生物学标志物为提供新的可能治疗靶点,以及综合血管老化评估系统 BVHS。加强心血管健康和内皮功能的评估,对风险人群心血管疾病的发生和心血管疾病患者不良事件的发生具有重要意义。

相似文献

本文引用的文献

3
Update on Hypertension Research in 2021.2021 年高血压研究进展。
Hypertens Res. 2022 Aug;45(8):1276-1297. doi: 10.1038/s41440-022-00967-4. Epub 2022 Jul 5.
5

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验